[CYP2C19*17 carrier status is significantly associated with enhanced response to clopidogrel and an increased risk of bleeding.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE